ITM To Announce Quality Of Life Data From The Phase 3 COMPETE Trial In Patients With Gastroenteropancreatic Neuroendocrine Tumors (GEP-Nets) At ASCO 2026
ताजा समाचार र हेडलाइनहरू
(MENAFN - GlobeNewsWire - Nasdaq) Garching / Munich, April 21, 2026 –– ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutic...
समाचार